Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SCMP > SEC Filings for SCMP > Form 8-K on 31-May-2013All Recent SEC Filings

Show all filings for SUCAMPO PHARMACEUTICALS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for SUCAMPO PHARMACEUTICALS, INC.


31-May-2013

Entry into a Material Definitive Agreement, Financial Statements an


Item 1.01. Entry into a Material Definitive Agreement.

On May 28, 2013, Sucampo Pharmaceuticals, Inc. (the "Company") entered into a consulting agreement with Gayle R. Dolecek, P.D., who resigned from his position as Executive Advisor, Research and Development Affairs of the Company and his employment at the Company, effective May 31, 2013. He will remain as a class 2 member of the board of directors of the Company.

Under the terms of the consulting agreement, Dr. Dolecek will, in addition to his services as a board member, provide research and development services to the Company from June 1, 2013 until May 31, 2014 at a certain number of hours per month and at a fixed amount of $170,000.

Exhibit Consulting Agreement.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

The following exhibit relating to Item 1.01 shall be deemed to be furnished, and not filed:

99.1 Consulting Agreement with Gayle R. Dolecek, P.D.


  Add SCMP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SCMP - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.